kentera (previously oxybutynin nicobrand)
teva b.v. - oksibutinin - urinarnu inkontinenciju, žuriti - urologicals - simptomatsko liječenje urgentne inkontinencije i / ili povećanu učestalost i hitnost urina kao što se može pojaviti kod odraslih bolesnika s nestabilnim mjehura.
driptane 5 mg tablete
mylan hrvatska d.o.o., koranska 2, zagreb, hrvatska - oksibutininklorid - tableta - 5 mg - urbroj: jedna tableta sadrži 5 mg oksibutininklorida
imbruvica (▼) 140 mg/1 kapsula kapsula, tvrda
inpharm co. d.o.o. banja luka - ibrutinib - kapsula, tvrda - 140 mg/1 kapsula - 1 kapsula, tvrda sadrži: 140 mg ibrutiniba
imbruvica (▼) 140 mg/1 kapsula kapsula, tvrda
inpharm co. d.o.o. banja luka - ibrutinib - kapsula, tvrda - 140 mg/1 kapsula - 1 kapsula, tvrda sadrži: 140 mg ibrutiniba
imbruvica 140 mg/1 kapsula kapsula, tvrda
inpharm co. d.o.o. banja luka - ibrutinib - kapsula, tvrda - 140 mg/1 kapsula - 1 kapsula, tvrda sadrži: 140 mg ibrutiniba
imbruvica 140 mg/1 kapsula kapsula, tvrda
inpharm co. d.o.o. banja luka - ibrutinib - kapsula, tvrda - 140 mg/1 kapsula - 1 kapsula, tvrda sadrži: 140 mg ibrutiniba
neopenotran forte 750 mg/1 vagitorija+ 200 mg/1 vagitorija vagitorija
medis international d.o.o. sarajevo - metronidazol, Миконазол - vagitorija - 750 mg/1 vagitorija+ 200 mg/1 vagitorija - 1 vagitorija sadrži: 750 mg metronidazola i 200 mg mikonazol nitrata
emselex
pharmaand gmbh - darifenacin hidrobromid - urinary incontinence, urge; urinary bladder, overactive - urologicals, lijekovi za mokrenje i inkontinencija - simptomatsko liječenje urgentne inkontinencije i / ili povećana učestalost i hitnost urina kao što se može pojaviti kod odraslih bolesnika s sindromom prekomjerne aktivnosti mokraćnog mjehura.
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
carbamazepine remedica retard 400 mg/1 tableta tableta sa produženim oslobađanjem
farmalogist allbix d.o.o. bijeljina - karbamazepin - tableta sa produženim oslobađanjem - 400 mg/1 tableta - 1 tableta sa produženim oslobađanjem sadrži: 400 mg karbamazepina